Callan Family Office’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384K Sell
2,055
-90
-4% -$16.5K 0.01% 911
2026
Q1
$405K Buy
2,145
+11
+0.5% +$2.32K 0.01% 838
2025
Q4
$424K Buy
+2,134
New +$431K 0.01% 826

Other funds holding THC

Callan Family Office's THC Position: Q2 2026 in Review

Callan Family Office reduced its Tenet Healthcare (THC) stake by 4.2% in Q2 2026, selling an estimated $16.5K and leaving 2,055 shares worth $384K. The position accounts for 0.01% of the portfolio, ranked #911.

Callan Family Office first reported a position in THC in Q4 2025 and has held it in 3 quarters since. The position peaked at $424K in Q4 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Callan Family Office held 2,055 shares of Tenet Healthcare worth $384K as of Q2 2026.
  • Callan Family Office sold 90 Tenet Healthcare shares in Q2 2026, an estimated $16.5K.
  • Tenet Healthcare made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #911 holding.
  • Callan Family Office first reported a position in Tenet Healthcare in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Tenet Healthcare position peaked at $424K in Q4 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.